Aker BioMarine AS reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 78.3 million compared to USD 69.1 million a year ago. Net loss was USD 11.9 million compared to USD 17.6 million a year ago.

Basic loss per share from continuing operations was USD 0.07 compared to USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.2 a year ago.